Literature DB >> 30844313

Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system.

Zhaoying Shi1,2, Huhu Xin1,2, Dandan Tian1,2, Jingru Lian1,2, Jianhui Wang1,2, Guanghui Liu1,2, Rensen Ran1,2, Songyuan Shi1,2, Zixuan Zhang1,2, Yu Shi3,4,5,6, Yi Deng1, Chunhui Hou1,2, Yonglong Chen1,2.   

Abstract

Precise single-base editing in Xenopus tropicalis would greatly expand the utility of this true diploid frog for modeling human genetic diseases caused by point mutations. Here, we report the efficient conversion of C-to-T or G-to-A in X. tropicalis using the rat apolipoprotein B mRNA editing enzyme catalytic subunit 1-XTEN-clustered regularly interspaced short palindromic repeat-associated protein 9 (Cas9) nickase-uracil DNA glycosylase inhibitor-nuclear localization sequence base editor [base editor 3 (BE3)]. Coinjection of guide RNA and the Cas9 mutant complex mRNA into 1-cell stage X. tropicalis embryos caused precise C-to-T or G-to-A substitution in 14 out of 19 tested sites with efficiencies of 5-75%, which allowed for easy establishment of stable lines. Targeting the conserved T-box 5 R237 and Tyr C28 residues in X. tropicalis with the BE3 system mimicked human Holt-Oram syndrome and oculocutaneous albinism type 1A, respectively. Our data indicate that BE3 is an easy and efficient tool for precise base editing in X. tropicalis.-Shi, Z., Xin, H., Tian, D., Lian, J., Wang, J., Liu, G., Ran, R., Shi, S., Zhang, Z., Shi, Y., Deng, Y., Hou, C., Chen, Y. Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system.

Entities:  

Keywords:  BE3; C-to-T conversion; Holt-Oram syndrome; Tbx5; oculocutaneous albinism type 1A

Mesh:

Year:  2019        PMID: 30844313     DOI: 10.1096/fj.201802661R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

Review 1.  Advancing genetic and genomic technologies deepen the pool for discovery in Xenopus tropicalis.

Authors:  Anneke Kakebeen; Andrea Wills
Journal:  Dev Dyn       Date:  2019-07-09       Impact factor: 3.780

2.  Expanding the CRISPR/Cas genome-editing scope in Xenopus tropicalis.

Authors:  Zhaoying Shi; Hao Jiang; Guanghui Liu; Songyuan Shi; Xuan Zhang; Yonglong Chen
Journal:  Cell Biosci       Date:  2022-07-08       Impact factor: 9.584

3.  CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.

Authors:  Thomas Naert; Dieter Tulkens; Tom Van Nieuwenhuysen; Joanna Przybyl; Suzan Demuynck; Matt van de Rijn; Mushriq Al-Jazrawe; Benjamin A Alman; Paul J Coucke; Kim De Leeneer; Christian Vanhove; Savvas N Savvides; David Creytens; Kris Vleminckx
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 12.779

Review 4.  Advances in engineering CRISPR-Cas9 as a molecular Swiss Army knife.

Authors:  Grace A Meaker; Emma J Hair; Thomas E Gorochowski
Journal:  Synth Biol (Oxf)       Date:  2020-10-24

5.  Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis.

Authors:  Rensen Ran; Lanxin Li; Zhaoying Shi; Guanghui Liu; Hao Jiang; Liangchen Fang; Tingting Xu; Jixuan Huang; Weiqi Chen; Yonglong Chen
Journal:  Mol Oncol       Date:  2022-08-18       Impact factor: 7.449

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.